Mayada Fawzy Sedik Farghaly

South Egypt Cancer Institute

Assiut University

Department
Department of Medical Oncology
MIS Email
mayada@aun.edu.eg
Office
-
Google Scholar
google_scholar
Ph. D. In () , , 2014
M. Sc. In () , , 2007
B. Sc. In () , , 2002

Lecturer South Egypt Cancer Institute, ِِAssiut University , 2014
# Title Research Year
1 Relation of Estrogen Receptor Expression to Recurrence and Survival in Early and Locally Advanced Breast Cancer
 		2021
2 Relation of Estrogen Receptor Expression to Recurrence and Survival in Early and Locally Advanced Breast Cancer
 		2021
3 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study 2021
4 Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin 2021
5 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study 2021
6 Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin 2021
7 Relation of Estrogen Receptor Expression to Recurrence and Survival in Early and Locally Advanced Breast Cancer
 		2021
8 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
 		2020
9 Right and Left Colon Cancer: Clinico-Pathological Features and Treatment Results (South Egypt
Cancer Institute Experience) 		2020
10 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
 		2020
11 Is survival with Conservative Breast Therapy becoming Superior to that with Modified Radical Mastectomy alone for the Treatment of Early Breast Cancer in this Era? 2020
12 Is survival with Conservative Breast Therapy becoming Superior to that with Modified Radical Mastectomy alone for the Treatment of Early Breast Cancer in this Era? 2020
13 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
 		2020
14 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
 		2019
15 The Prognostic Implication of CD49d Expression by Flow Cytometry and Trisomy 12 Detection by Fluorescent in situ Hybridization in Chronic Lymphocytic Leukemia 2019
16 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
 		2019
17 Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
 		2019
18 Signet ring carcinoma of the stomach: impact on prognosis and outcome
 		2018
19 Signet ring carcinoma of the stomach: impact on prognosis and outcome
 		2018
20 Preoperative Conformal Radiotherapy Concurrently with Paclitaxel/Carboplatin in Gastric Cancer 2018
21 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX 2018
22 Signet ring carcinoma of the stomach: impact on prognosis and outcome
 		2018
23 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX 2018
24 Adjuvant Chemotherapy in High Risk Colon Cancer Standard FOLFOX or XELOX versus Short Duration of XELOX 2018
25 PATTERN AND OUTCOME OF ADVANCED GASTRIC CANCER IN SOUTH EGYPT CANCER INSTITUTE FROM 2005 TO 2014 2015
26 PATTERN AND OUTCOME OF ADVANCED GASTRIC CANCER IN SOUTH EGYPT CANCER INSTITUTE FROM 2005 TO 2014 2015
27 PATTERN AND OUTCOME OF ADVANCED GASTRIC CANCER IN SOUTH EGYPT CANCER INSTITUTE FROM 2005 TO 2014 2015
28 Gemcitabine and Carboplatin in Patients with Refractory or Progressive Metastatic Breast Cancer after Treatment 2014

الجمعيات العلمية و النقابات :